The Nordic Countries as a Cohort for Pharmacoepidemiological Research
2009 · Basic & Clinical Pharmacology & Toxicology · 572 citations
https://doi.org/10.1111/j.1742-7843.2009.00494.x
B
Björn Wettermark
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
352
Papers
11.1K
Citations
54
h-index
155
i10-index
Björn Wettermark is an academic researcher from Uppsala University. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Pharmaceutical Practices and Patient Outcomes & Medication Adherence and Compliance. The author has an h-index of 54, co-authored 300 publications.
ORCID: 0000-0003-0531-2516Papers by this author
worksBarriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
2018 · Frontiers in Public Health · 152 citations
https://doi.org/10.3389/fpubh.2018.00328
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
2018 · American Journal of Kidney Diseases · 91 citations
https://doi.org/10.1053/j.ajkd.2018.08.013
Enhancing the rational use of new medicines across European health care systems
2008 · European Journal of Clinical Pharmacology · 71 citations
https://doi.org/10.1007/s00228-008-0537-z
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
2022 · Scientific Reports · 38 citations
https://doi.org/10.1038/s41598-022-16357-2
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
2018 · European Journal of Clinical Pharmacology · 28 citations
https://doi.org/10.1007/s00228-018-2456-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat